Adrian Adams Impel Pharmaceuticals Inc (IMPL) insider trading activity

IMPL Quotes by TradingView

Adrian Adams is COB, CEO and President of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 20,000 shares of IMPL, which is worth approximately $400. The most recent transaction as insider was on Aug 18, 2021, when has been sold 20,000 shares (Common Stock) at a price of $14.87 per share, resulting in proceeds of $297,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $400

ADRIAN ADAMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2021
BUY
Open market or private purchase
$297,400 $14.87 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

AKBA
Akebia Therapeutics, Inc. Healthcare
ACRX
ACELRX PHARMACEUTICALS INC Healthcare
AA

Adrian Adams

COB, CEO and President
Hayward, CA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMPL